Insufficient scRNA-seq data for expression of PLA2G3 at single-cell level.
Insufficient scRNA-seq data for expression of PLA2G3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 56% | 313.18 | 322 / 578 | 54% | 4.63 | 629 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 91% | 10.95 | 41 / 45 |
esophagus | 38% | 588.33 | 556 / 1445 | 48% | 4.11 | 88 / 183 |
skin | 71% | 1255.20 | 1293 / 1809 | 10% | 0.79 | 46 / 472 |
thymus | 25% | 58.58 | 164 / 653 | 33% | 1.37 | 200 / 605 |
uterus | 3% | 31.68 | 5 / 170 | 55% | 5.44 | 251 / 459 |
intestine | 3% | 8.10 | 28 / 966 | 39% | 3.06 | 207 / 527 |
breast | 8% | 18.96 | 35 / 459 | 31% | 2.02 | 347 / 1118 |
stomach | 12% | 39.76 | 42 / 359 | 27% | 1.54 | 77 / 286 |
bladder | 0% | 0 | 0 / 21 | 29% | 2.01 | 145 / 504 |
kidney | 17% | 28.64 | 15 / 89 | 5% | 0.15 | 44 / 901 |
ovary | 0% | 0 | 0 / 180 | 20% | 0.55 | 87 / 430 |
pancreas | 0% | 0 | 0 / 328 | 16% | 0.51 | 29 / 178 |
prostate | 7% | 16.08 | 18 / 245 | 3% | 0.06 | 15 / 502 |
brain | 2% | 4.14 | 62 / 2642 | 1% | 0.03 | 10 / 705 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 2 / 406 |
adipose | 0% | 0.87 | 2 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.21 | 1 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.20 | 1 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.44 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010744 | Biological process | positive regulation of macrophage derived foam cell differentiation |
GO_0060271 | Biological process | cilium assembly |
GO_0007288 | Biological process | sperm axoneme assembly |
GO_0042116 | Biological process | macrophage activation |
GO_0046488 | Biological process | phosphatidylinositol metabolic process |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_2001135 | Biological process | regulation of endocytic recycling |
GO_0006658 | Biological process | phosphatidylserine metabolic process |
GO_0019372 | Biological process | lipoxygenase pathway |
GO_0060376 | Biological process | positive regulation of mast cell differentiation |
GO_0031394 | Biological process | positive regulation of prostaglandin biosynthetic process |
GO_0034375 | Biological process | high-density lipoprotein particle remodeling |
GO_1900017 | Biological process | positive regulation of cytokine production involved in inflammatory response |
GO_1903595 | Biological process | positive regulation of histamine secretion by mast cell |
GO_0043303 | Biological process | mast cell degranulation |
GO_0002532 | Biological process | production of molecular mediator involved in inflammatory response |
GO_0034374 | Biological process | low-density lipoprotein particle remodeling |
GO_0001675 | Biological process | acrosome assembly |
GO_0046470 | Biological process | phosphatidylcholine metabolic process |
GO_0046473 | Biological process | phosphatidic acid metabolic process |
GO_0032308 | Biological process | positive regulation of prostaglandin secretion |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0046337 | Biological process | phosphatidylethanolamine metabolic process |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0048469 | Biological process | cell maturation |
GO_0046471 | Biological process | phosphatidylglycerol metabolic process |
GO_1900222 | Biological process | negative regulation of amyloid-beta clearance |
GO_0050482 | Biological process | arachidonic acid secretion |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0055037 | Cellular component | recycling endosome |
GO_0005814 | Cellular component | centriole |
GO_0047498 | Molecular function | calcium-dependent phospholipase A2 activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | PLA2G3 |
Protein name | Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3) |
Synonyms | |
Description | FUNCTION: Secretory calcium-dependent phospholipase A2 that primarily targets extracellular phospholipids. Hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids without apparent head group selectivity . Contributes to phospholipid remodeling of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) particles. Hydrolyzes LDL phospholipids releasing unsaturated fatty acids that regulate macrophage differentiation toward foam cells . May act in an autocrine and paracrine manner . Secreted by immature mast cells, acts on nearby fibroblasts upstream to PTDGS to synthesize prostaglandin D2 (PGD2), which in turn promotes mast cell maturation and degranulation via PTGDR . Secreted by epididymal epithelium, acts on immature sperm cells within the duct, modulating the degree of unsaturation of the fatty acyl components of phosphatidylcholines required for acrosome assembly and sperm cell motility. Facilitates the replacement of fatty acyl chains in phosphatidylcholines in sperm membranes from omega-6 and omega-9 to omega-3 polyunsaturated fatty acids (PUFAs). Coupled to lipoxygenase pathway, may process omega-6 PUFAs to generate oxygenated lipid mediators in the male reproductive tract (By similarity). At pericentrosomal preciliary compartment, negatively regulates ciliogenesis likely by regulating endocytotic recycling of ciliary membrane protein . Coupled to cyclooxygenase pathway provides arachidonate to generate prostaglandin E2 (PGE2), a potent immunomodulatory lipid in inflammation and tumorigenesis . At colonic epithelial barrier, preferentially hydrolyzes phospholipids having arachidonate and docosahexaenoate at sn-2 position, contributing to the generation of oxygenated metabolites involved in colonic stem cell homeostasis . Releases C16:0 and C18:0 lysophosphatidylcholine subclasses from neuron plasma membranes and promotes neurite outgrowth and neuron survival . . |
Accessions | Q9NZ20 ENST00000215885.4 |